Insider · CIK 0002069951

Cote Elissa S.

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

Transactions

Companies

Filings

CIK

0002069951

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-07	VTGNVistagen Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	Chief Corp Development Officer	AAward	+75K sh	—	—	75,000
2025-06-23	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Corp Development Officer	AAward	+150K sh	—	—	150,000

C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVE

SOUTH SAN FRANCISCO, CA, 94080